{"id":540034,"date":"2021-04-22T17:48:01","date_gmt":"2021-04-22T17:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=540034"},"modified":"2021-04-22T17:48:01","modified_gmt":"2021-04-22T17:48:01","slug":"urea-cycle-disorders-market-size-share-trends-epidemiology-and-competitive-insights-report-2030-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/urea-cycle-disorders-market-size-share-trends-epidemiology-and-competitive-insights-report-2030-delveinsight_540034.html","title":{"rendered":"Urea Cycle Disorders Market Size & Share, Trends, Epidemiology and Competitive Insights Report 2030 | DelveInsight"},"content":{"rendered":"
\"Urea<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Urea Cycle Disorders – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Urea Cycle Disorders, historical and forecasted epidemiology as well as the Urea Cycle Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/div>\n

A Urea Cycle Disorder (UCD) is a genetic disorder that results in a deficiency of some major enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the bloodstream. The urea cycle involves a series of biochemical steps in which nitrogen, a waste product of protein metabolism, is changed to a compound called urea and removed from the blood. Normally, the urea is removed from the body through the urine. In urea cycle disorders, nitrogen builds up in the blood in the form of ammonia, a highly toxic substance, resulting in hyperammonemia (elevated blood ammonia). Ammonia then reaches the brain through the blood, where it can cause irreversible brain damage, coma, and\/or death. The onset and severity of urea cycle disorders is highly variable. The severity correlates with the amount of urea cycle enzyme function.<\/p>\n

DelveInsight’s “Urea Cycle Disorders Market Report 2030<\/strong><\/a>” report delivers an in-depth understanding of the Urea Cycle Disorders, historical and forecasted epidemiology as well as the Urea Cycle Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

A few of the enzymes which are involved in the Urea Cycle Disorder, collectively known as inborn errors of urea synthesis, or urea cycle enzyme defects; each is referred to by the initials of the missing enzyme: CPS1 (Carbamoyl Phosphate Synthetase), NAGS (N-Acetylglutamate Synthetase), OTC Deficiency (Ornithine Transcarbamylase), AS (Argininosuccinic Acid Synthetase (Citrullinemia)), ASL (Argininosuccinate Lyase (Argininosuccinic Aciduria)), and AG (Arginase).<\/p>\n

In children with severe UCD, the symptoms will develop within the first 24 hours of life. Symptoms in children with mild or moderate UCD, who do not show symptoms until early childhood, may include: Vomiting, nausea, Mental confusion or hyperactive behaviour, Tired often and\/or hard to awaken, Coma, etc.<\/p>\n

View report: https:\/\/www.delveinsight.com\/report-store\/urea-cycle-disorders-market<\/a><\/strong><\/p>\n

Treatment is a lifelong process that doesn’t cure the condition, but it can effectively manage the symptoms. The child’s treatment probably will involve:<\/p>\n

•Low protein, high-calorie diet<\/p>\n

•Medications<\/p>\n

•Amino acid supplements<\/p>\n

•Liver transplantation<\/p>\n

Geography Covered<\/strong><\/p>\n